<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T11:33:18Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3547366" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:3547366</identifier>
        <datestamp>2013-01-17</datestamp>
        <setSpec>eurjhf</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Eur J Heart Fail</journal-id>
              <journal-id journal-id-type="iso-abbrev">Eur. J. Heart Fail</journal-id>
              <journal-id journal-id-type="publisher-id">eurjhf</journal-id>
              <journal-id journal-id-type="hwp">eurjhf</journal-id>
              <journal-title-group>
                <journal-title>European Journal of Heart Failure</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1388-9842</issn>
              <issn pub-type="epub">1879-0844</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC3547366</article-id>
              <article-id pub-id-type="pmcid">PMC3547366</article-id>
              <article-id pub-id-type="pmc-uid">3547366</article-id>
              <article-id pub-id-type="pmid">23112002</article-id>
              <article-id pub-id-type="doi">10.1093/eurjhf/hfs165</article-id>
              <article-id pub-id-type="publisher-id">hfs165</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Diagnosis</subject>
                </subj-group>
                <series-title>Editor's choice</series-title>
              </article-categories>
              <title-group>
                <article-title>High prevalence of undetected heart failure in long-term care residents: findings from the Heart Failure in Care Homes (HFinCH) study</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hancock</surname>
                    <given-names>Helen C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1">1</xref>
                  <xref ref-type="aff" rid="af2">2</xref>
                  <xref ref-type="corresp" rid="cor1">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Close</surname>
                    <given-names>Helen</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1">1</xref>
                  <xref ref-type="aff" rid="af2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mason</surname>
                    <given-names>James M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1">1</xref>
                  <xref ref-type="aff" rid="af2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Murphy</surname>
                    <given-names>Jerry J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1">1</xref>
                  <xref ref-type="aff" rid="af3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fuat</surname>
                    <given-names>Ahmet</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1">1</xref>
                  <xref ref-type="aff" rid="af3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Singh</surname>
                    <given-names>Raj</given-names>
                  </name>
                  <xref ref-type="aff" rid="af3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wood</surname>
                    <given-names>Esther</given-names>
                  </name>
                  <xref ref-type="aff" rid="af3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>de Belder</surname>
                    <given-names>Mark</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brennan</surname>
                    <given-names>Gill</given-names>
                  </name>
                  <xref ref-type="aff" rid="af3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hussain</surname>
                    <given-names>Nehal</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kumar</surname>
                    <given-names>Nitin</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wilson</surname>
                    <given-names>Doug</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1">1</xref>
                  <xref ref-type="aff" rid="af2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hungin</surname>
                    <given-names>A. Pali S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1">1</xref>
                </contrib>
              </contrib-group>
              <aff id="af1">
                <label>1</label>
                <addr-line>Durham Clinical Trials Unit</addr-line>
              </aff>
              <aff id="af2">
                <label>2</label>
                <addr-line>School of Medicine, Pharmacy and Health, Durham University, Queen's Campus, Wolfson Research Institute, University Boulevard, Stockton-on-Tees TS17 6BH, UK</addr-line>
              </aff>
              <aff id="af3">
                <label>3</label>
                <addr-line>Department of Cardiology, Darlington Memorial Hospital, County Durham and Darlington NHS Foundation Trust, Hollyhurst Road, Darlington, UK</addr-line>
              </aff>
              <aff id="af4">
                <label>4</label>
                <addr-line>Department of Cardiology, The James Cook University Hospital, South Tees Acute Hospitals NHS Foundation Trust, Marton Road, Middlesbrough, UK</addr-line>
              </aff>
              <author-notes>
                <corresp id="cor1"><label>*</label>Corresponding author. Tel: +44 191 33 40826, Fax: +44 191 33 40374, Email: <email>helen.hancock@durham.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <month>2</month>
                <year>2013</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>30</day>
                <month>10</month>
                <year>2012</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>30</day>
                <month>10</month>
                <year>2012</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
              <volume>15</volume>
              <issue>2</issue>
              <fpage>158</fpage>
              <lpage>165</lpage>
              <history>
                <date date-type="received">
                  <day>6</day>
                  <month>7</month>
                  <year>2012</year>
                </date>
                <date date-type="rev-recd">
                  <day>10</day>
                  <month>8</month>
                  <year>2012</year>
                </date>
                <date date-type="accepted">
                  <day>29</day>
                  <month>8</month>
                  <year>2012</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Â© The Author 2012. Published by Oxford University Press on behalf of the European Society of Cardiology.</copyright-statement>
                <copyright-year>2012</copyright-year>
                <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
                  <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits non-commercial reuse, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oup.com.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="hfs165.pdf"/>
              <abstract>
                <sec>
                  <title>Aims</title>
                  <p>Diagnosis of heart failure in older people in long-term care is challenging because of co-morbidities, cognitive deficit, polypharmacy, immobility, and poor access to services. This study aimed to ascertain heart failure prevalence and clinical management in this population.</p>
                </sec>
                <sec>
                  <title>Methods and results</title>
                  <p>A total of 405 residents, aged 65â100 years, in 33 UK care facilities were prospectively enrolled between April 2009 and June 2010. The presence of heart failure was determined using European Society of Cardiology guidelines, modified where necessary for immobility. Evaluation of symptoms and signs, functional capacity, and quality of life, portable on-site echocardiography, and medical record review were completed in 399 cases. The point prevalence of heart failure was 22.8% [<italic>n</italic> = 91, 95% confidence interval (CI) 18.8â27.2%]; of these, 62.7% (<italic>n</italic> = 57, 95% CI 59.6â66.5%) had heart failure with preserved ejection fraction and 37.3% had left ventricular systolic dysfunction (<italic>n</italic> = 34, 95% CI 34.8â40.5%). A total of 76% (<italic>n</italic> = 61) of previous diagnoses of heart failure were not confirmed, and up to 90% (<italic>n</italic> = 82) of study cases were new. No symptoms or signs were reliable predictors of heart failure.</p>
                </sec>
                <sec>
                  <title>Conclusion</title>
                  <p>Heart failure was diagnosed in almost a quarter of residents: the prevalence was substantially higher than in other populations. The majority of heart failure cases were undiagnosed, while three-quarters of previously recorded cases were misdiagnosed. Common symptoms and signs appear to have little clinical utility in this population. Early, accurate differential diagnosis is key to the effective management of heart failure; this may be failing in long-term care facilities.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p>ISRCTN19781227</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Heart failure with preserved ejection fraction (HFpEF)</kwd>
                <kwd>Diagnosis</kwd>
                <kwd>Prevalence</kwd>
                <kwd>Older people</kwd>
                <kwd>Long-term care</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <p>
              <related-article id="d34e279" related-article-type="article-reference" ext-link-type="doi" xlink:href="10.1093/eurjhf/hfs213">
                <bold>See page 125 for the editorial comment on this article (doi:10.1093/eurjhf/hfs213)</bold>
              </related-article>
            </p>
            <sec id="s1">
              <title>Introduction</title>
              <p>Heart failure (HF) has a progressive, negative impact upon quality of life, morbidity, and mortality, which may be improved substantially by accurate diagnosis and management. Although the prevalence of HF is highest in older people, <sup><xref ref-type="bibr" rid="HFS165C1">1</xref></sup> diagnosis and management are likely to be least comprehensive in long-term care.<sup><xref ref-type="bibr" rid="HFS165C2">2</xref>â<xref ref-type="bibr" rid="HFS165C5">5</xref></sup> In this setting, where access to health services may be limited, acute care often takes precedence over chronic care and preventative needs.<sup><xref ref-type="bibr" rid="HFS165C6">6</xref></sup> In practice, HF symptoms are often non-specific, physical signs may be difficult to elicit,<sup><xref ref-type="bibr" rid="HFS165C7">7</xref>â<xref ref-type="bibr" rid="HFS165C12">12</xref></sup> and, for unknown reasons, the prevalence of cardiovascular co-morbidities may be lower in older people.<sup><xref ref-type="bibr" rid="HFS165C13">13</xref></sup> As long-term care residents are often unable to attend outside clinics or diagnostic facilities, the lack of availability of echocardiography in this setting further complicates diagnosis and management.<sup><xref ref-type="bibr" rid="HFS165C14">14</xref>â<xref ref-type="bibr" rid="HFS165C17">17</xref></sup> Internationally, the most relevant studies suggest a prevalence of 10â42% in long-term care,<sup><xref ref-type="bibr" rid="HFS165C9">9</xref>,<xref ref-type="bibr" rid="HFS165C18">18</xref>,<xref ref-type="bibr" rid="HFS165C19">19</xref></sup> 6.7% in the general population,<sup><xref ref-type="bibr" rid="HFS165C20">20</xref></sup> and 46% in older people presenting to hospital with HF symptoms.<sup><xref ref-type="bibr" rid="HFS165C11">11</xref></sup> While data on undiagnosed HF are inherently difficult to obtain, current evidence suggests that an accurate diagnosis may be missed in up to half of cases.<sup><xref ref-type="bibr" rid="HFS165C18">18</xref>,</sup><sup><xref ref-type="bibr" rid="HFS165C21">21</xref>â<xref ref-type="bibr" rid="HFS165C24">24</xref></sup> Despite the higher prevalence of HF in older people, there is a paucity of research that examines either assessment and diagnostic practices or care provision for this debilitating disease. The relative prevalence of HF with reduced ejection fraction [left ventricular systolic dysfunction (LVSD) or HFrEF] and preserved ejection fraction (HFpEF) is unknown, though HFpEF may account for &gt;50% of HF hospitalizations in the elderly.<sup><xref ref-type="bibr" rid="HFS165C25">25</xref>â<xref ref-type="bibr" rid="HFS165C28">28</xref></sup> The aim of this study was to establish the overall prevalence of HF (and by type) in long-term care facilities using on-site echocardiography and a review of treatment for existing diagnoses of HF.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <sec id="s2a">
                <title>Study population</title>
                <p>Residents from long-term care facilities (UK residential and nursing homes) in Teesside, North East England, aged â¥65 years without terminal disease and who were permanently resident were eligible to participate. Study data were collected over a 14-month period from April 2009. Initial and process consent was sought directly from the resident, or from their relative (or a consultee) when a resident lacked the capacity to provide informed consent. Capacity to consent was determined by the Mini Mental State Examination (MMSE)<sup><xref ref-type="bibr" rid="HFS165C29">29</xref></sup> and process consent using the abbreviated mental tests score (AMTS)<sup><xref ref-type="bibr" rid="HFS165C30">30</xref></sup> prior to assessments. Anonymized demographic details (date of birth, gender, and ethnicity) of all eligible residents (including non-participants) were extracted.</p>
              </sec>
              <sec id="s2b">
                <title>Investigation</title>
                <p>Participants underwent a diagnostic assessment within each facility, including MMSE,<sup><xref ref-type="bibr" rid="HFS165C29">29</xref></sup> demographic information, medication, and past medical history, quality of life assessment (EuroQol: EQ-5D and EQ-VAS),<sup><xref ref-type="bibr" rid="HFS165C31">31</xref></sup> physical examination, electrocardiography, echocardiography,<sup><xref ref-type="bibr" rid="HFS165C32">32</xref></sup> and blood sampling. Portable echocardiograms (Vivid-i, application software version 6.2.0, system software 2.1.16, 3RS probe) were performed by a British Society of Echocardiography (BSE)-accredited physiologist according to European Society of Cardiology (ESC) guidelines,<sup><xref ref-type="bibr" rid="HFS165C19">19</xref>,<xref ref-type="bibr" rid="HFS165C25">25</xref></sup> and electrocardiograms (ECGs; GE MAC 1600, cardiosoft version 6.5) by a trained technician. Full echocardiograms, including colour Doppler, were performed, and images were stored for off-line assessment. Linear and M-mode cardiac chamber measurements were obtained from the parasternal long and short axis view in accordance with American Society of Cardiology (ASC) recommendations.<sup><xref ref-type="bibr" rid="HFS165C33">33</xref></sup> All assessments were conducted by the study team; echocardiography, ECG, and physical assessment findings were blinded from each other; findings were reviewed by a consultant cardiologist (J.J.M.) who made the definitive diagnosis of HF (LVSD or HFpEF). Findings were subsequently reviewed by a second HF specialist (A.F.) who was blinded to the diagnosis (with 100% agreement). On completion of the study 12.5% (50) of echocardiograms were randomly selected and independently reported by a BSE-accredited cardiac physiologist (not involved in the study) to test the reliability and validity of the findings (with 100% agreement for significant left ventricular dysfunction and valve disease).</p>
              </sec>
              <sec id="s2c">
                <title>Differential definitions of heart failure</title>
                <p>Definitions of HF were based on ESC guidelines available at the time of the study,<sup><xref ref-type="bibr" rid="HFS165C19">19</xref>,<xref ref-type="bibr" rid="HFS165C25">25</xref></sup> modified for the potential impact of both cognitive impairment and immobility resulting from co-morbidities. Symptoms and signs compatible with HF were defined as: (i) breathlessness, graded as New York Heart Association (NYHA) class II, III, or IV; (ii) moderate oedema (up to the knees bilaterally); or (iii) mild oedema (confined to the ankles) + one other clinical sign (see below); (iv) mild oedema and taking at least furosemide 40 mg (or equivalent) per day; or (v) two or more other signs [raised jugular venous pressure (JVP), lung crackles, respiratory rate &gt;20/min, third heart sound].</p>
                <p>Left ventricular systolic dysfunction was assessed: using the âeyeballâ method as normal, or mildly, moderately, or severely impaired; by left ventricular ejection fraction (LVEF) calculated by Simpson's rule; and by wall motion index using the ASC recommendations.<sup><xref ref-type="bibr" rid="HFS165C33">33</xref></sup> Doppler and tissue Doppler measurements of the longitudinal function of the heart were used to determine left ventricular diastolic dysfunction (LVDD). Measurements of the ratio of early transmitral flow velocity and early mitral annular velocity (E/E') were recorded at both the septum and lateral wall.</p>
                <p>All residents with clinical features and either an LVEF of â¤50% or whose left ventricular systolic function was assessed by âeyeballâ to be mildly, moderately, or severely impaired were classified as having HF due to LVSD. HFpEF was diagnosed in accordance with ESC guidelines<sup><xref ref-type="bibr" rid="HFS165C19">19</xref></sup> using clinical, echocardiographic, and brain natriuretic peptide (BNP) measurements. Patients with clinical features of HF whose LVEF was &gt;50% with an E/E' &gt;15, or those with an equivocal E/E' (8â15) but BNP &gt;200 pg/mL or N-terminal proBNP (NT-proBNP) &gt;220 pg/mL were diagnosed as having HFpEF.</p>
              </sec>
              <sec id="s2d">
                <title>Study endpoints</title>
                <p>Point prevalence was measured according to the clinical diagnosis of HF, and differentiated as LVSD, LVSD-HF, or HFpEF. Symptom and sign profiles (including MMSE, AMTS, and NYHA class), co-morbidities and prescribed medications, quality of life (EQ-5D and EQ-VAS),<sup><xref ref-type="bibr" rid="HFS165C31">31</xref></sup> and characteristics of care provision and diagnostic agreement in general practice and care facility records were reported for those with and without HF.</p>
              </sec>
              <sec id="s2e">
                <title>Data analysis</title>
                <p>All calculations were performed using SPSS version 19. Continuous data are expressed as mean, range, and standard deviation (SD) (unless otherwise stated) and binary data as proportions. A value of <italic>P</italic> &lt; 0.05 was considered significant for the purpose of hypothesis generation. Comparisons between groups were made using Student's <italic>t</italic>-test for continuous data and Fisher's exact test for proportions. Residents with incomplete echocardiographic assessment were excluded from the analysis.</p>
              </sec>
              <sec id="s2f">
                <title>Ethical approval</title>
                <p>The study protocol received prior local research management and governance and national ethics approvals, and the study complies with the Declaration of Helsinki. Informed consent was obtained from all subjects or guardians.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s3">
              <title>Results</title>
              <sec id="s3a">
                <title>Study population</title>
                <p>Thirty-three care facilities (with a total of 1701 beds) agreed to participate in the study; two declined. Study participants were registered with 23 general practices (including 93 primary care physicians).</p>
                <p>Data were collected on non-participating residents; 529 residents (of the total 1701) were judged by care facility managers to be ineligible predominantly due to concerns over the balance of risks and benefits of participating. Of the remaining 1172 eligible residents, consent for participation was obtained for 405 (35%). The primary reason for non-participation was relatives declining on behalf of residents due to similar concerns. Portable echocardiography was not possible in six participants; 399 participants with complete data are reported.</p>
                <p>Participant age ranged from 65 to 100 years (mean 84 years); the majority (54%) were â¥85 years. Participants were almost exclusively white British (99%) and the majority were female (74%). Eligible non-participants and participants showed similar baseline demographic characteristics (see <italic>TableÂ <xref ref-type="table" rid="HFS165TB1">1</xref></italic>), demonstrating no discrimination on the basis of age, gender, or ethnicity. Baseline characteristics of participants are shown in <italic>TableÂ <xref ref-type="table" rid="HFS165TB2">2</xref></italic>.
<table-wrap id="HFS165TB1" position="float"><label>Table 1</label><caption><p>Care facility residents: comparison of participants and non-participants</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1">Characteristics<hr/></th><th align="left" rowspan="1" colspan="1">Participants (<italic>n</italic> = 399)</th><th align="left" rowspan="1" colspan="1">Non-participants (<italic>n</italic> = 767)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">65â74</td><td rowspan="1" colspan="1">46 (11.5%)</td><td rowspan="1" colspan="1">83 (10.8%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">75â84</td><td rowspan="1" colspan="1">136 (34.1%)</td><td rowspan="1" colspan="1">294 (38.3%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">85+</td><td rowspan="1" colspan="1">217 (54.4%)</td><td rowspan="1" colspan="1">390 (50.8%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mean (SD, range)</td><td rowspan="1" colspan="1">84.2 (7.2, 65â100)</td><td rowspan="1" colspan="1">84.5 (7.6, 65â106)</td></tr><tr><td rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">105 (26.3%)</td><td rowspan="1" colspan="1">198 (25.8%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">294 (73.7%)</td><td rowspan="1" colspan="1">569 (74.1%)</td></tr><tr><td rowspan="1" colspan="1">Ethnicity</td><td rowspan="1" colspan="1">White British</td><td rowspan="1" colspan="1">393 (98.5%)</td><td rowspan="1" colspan="1">767 (100%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">White European</td><td rowspan="1" colspan="1">6 (1.5%)</td><td rowspan="1" colspan="1">0 (0%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Other</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td></tr></tbody></table></table-wrap>
<table-wrap id="HFS165TB2" position="float"><label>TableÂ 2</label><caption><p>Characteristics of participants by (study-determined) heart failure status</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1">Characteristics<hr/></th><th align="left" rowspan="1" colspan="1">No HF (A), <italic>n</italic> = 308</th><th align="left" rowspan="1" colspan="1">LVSD (B), <italic>n</italic> =34 (%)<sup>a</sup></th><th align="left" rowspan="1" colspan="1">HFpEF (C), <italic>n</italic> = 57</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value (A vs. B)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value (A vs. C)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">65â74</td><td rowspan="1" colspan="1">42 (13.6%)</td><td rowspan="1" colspan="1">4 (11.8%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0.829<sup>g</sup></td><td rowspan="1" colspan="1">0.004<sup>g</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">75â84</td><td rowspan="1" colspan="1">109 (35.4%)</td><td rowspan="1" colspan="1">10 (29.4%)</td><td rowspan="1" colspan="1">17 (29.8%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">85+</td><td rowspan="1" colspan="1">157 (51.0%)</td><td rowspan="1" colspan="1">20 (58.8%)</td><td rowspan="1" colspan="1">40 (70.2%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mean<sup>b</sup></td><td rowspan="1" colspan="1">83.5 (7.3, 65â99)</td><td rowspan="1" colspan="1">84.3 (6.6, 70â98)</td><td rowspan="1" colspan="1">87.6 (5.6, 75â100)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">82 (26.6%)</td><td rowspan="1" colspan="1">13 (38.2%)</td><td rowspan="1" colspan="1">10 (17.5%)</td><td rowspan="1" colspan="1">0.077</td><td rowspan="1" colspan="1">0.068</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">226 (73.4%)</td><td rowspan="1" colspan="1">21 (61.8%)</td><td rowspan="1" colspan="1">47 (82.5%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Ethnicity</td><td rowspan="1" colspan="1">White British</td><td rowspan="1" colspan="1">303 (98.4%)</td><td rowspan="1" colspan="1">34 (100%)</td><td rowspan="1" colspan="1">56 (98.2%)</td><td rowspan="1" colspan="1">0.584<sup>g</sup></td><td rowspan="1" colspan="1">0.606<sup>g</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">White European</td><td rowspan="1" colspan="1">5 (1.6%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Care facility type<sup>c</sup></td><td rowspan="1" colspan="1">Nursing</td><td rowspan="1" colspan="1">94 (30.5%)</td><td rowspan="1" colspan="1">9 (26.5%)</td><td rowspan="1" colspan="1">17 (29.8%)</td><td rowspan="1" colspan="1">0.314<sup>g</sup></td><td rowspan="1" colspan="1">0.635<sup>g</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Residential</td><td rowspan="1" colspan="1">202 (65.6%)</td><td rowspan="1" colspan="1">22 (64.7%)</td><td rowspan="1" colspan="1">39 (68.4%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Dementia</td><td rowspan="1" colspan="1">12 (3.9%)</td><td rowspan="1" colspan="1">3 (8.8%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">MMSE score<sup>d</sup></td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">36 (11.7%)</td><td rowspan="1" colspan="1">4 (11.8%)</td><td rowspan="1" colspan="1">5 (8.8%)</td><td rowspan="1" colspan="1">0.358<sup>g</sup></td><td rowspan="1" colspan="1">0.746<sup>g</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1â23</td><td rowspan="1" colspan="1">174 (56.5%)</td><td rowspan="1" colspan="1">15 (44.1%)</td><td rowspan="1" colspan="1">31 (54.4%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">â¥24</td><td rowspan="1" colspan="1">98 (31.8%)</td><td rowspan="1" colspan="1">15 (44.1%)</td><td rowspan="1" colspan="1">21 (36.8%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">MMSE description</td><td rowspan="1" colspan="1">Alert</td><td rowspan="1" colspan="1">287 (93.2)</td><td rowspan="1" colspan="1">34 (100%)</td><td rowspan="1" colspan="1">54 (94.7%)</td><td rowspan="1" colspan="1">0.304<sup>g</sup></td><td rowspan="1" colspan="1">0.905<sup>g</sup></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Drowsy</td><td rowspan="1" colspan="1">20 (6.5%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">3 (5.3%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Coma</td><td rowspan="1" colspan="1">1 (0.3%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">BMI<sup>e</sup></td><td rowspan="1" colspan="1">Mean<sup>b</sup></td><td rowspan="1" colspan="1">25.5 (5.4, 11â45)</td><td rowspan="1" colspan="1">26.2 (4.8, 18â36)</td><td rowspan="1" colspan="1">25.3 (4.6, 17â35)</td><td rowspan="1" colspan="1">0.535</td><td rowspan="1" colspan="1">0.961</td></tr><tr><td rowspan="1" colspan="1">EQ-5D</td><td rowspan="1" colspan="1">Mean<sup>b</sup></td><td rowspan="1" colspan="1">0.42 (0.36, â0.54 to 1)</td><td rowspan="1" colspan="1">0.57 (0.26, 0.08â1)</td><td rowspan="1" colspan="1">0.47 (0.35, â0.18 to 1)</td><td rowspan="1" colspan="1">0.920</td><td rowspan="1" colspan="1">0.972</td></tr><tr><td rowspan="1" colspan="1">EQ-VAS<sup>f</sup></td><td rowspan="1" colspan="1">Mean<sup>b</sup></td><td rowspan="1" colspan="1">61.2 (19.1, 10â100)</td><td rowspan="1" colspan="1">67.8 (18, 50â100)</td><td rowspan="1" colspan="1">65.2 (14.9, 40â90)</td><td rowspan="1" colspan="1">0.881</td><td rowspan="1" colspan="1">0.622</td></tr></tbody></table><table-wrap-foot><fn><p>BMI, body mass index; EQ, EuroQuol; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; LVSD, left ventricular systolic dysfunction; MMSE. Mini Mental State Examination; VAS, visual analogue scale.</p></fn><fn><p><sup>a</sup>For tabulation purposes, three cases of LVSD without clinical signs of heart failure are included</p></fn><fn><p><sup>b</sup>Mean, standard deviation, range</p></fn><fn><p><sup>c</sup>Residential homes are registered to provide personal and social care for people no longer able to live independently; nursing homes provide these services in addition to medical and nursing care; nursing homes additionally include specialist mental healthcare. Some facilities provide a mixture of levels of care.</p></fn><fn><p><sup>d</sup>A score of â¤23 required study consent by âconsultee declarationâ.</p></fn><fn><p><sup>e</sup>BMI available for 384 (96%) residents.</p></fn><fn><p><sup>f</sup>VAS score available for 120 (30%) residents.</p></fn><fn><p><sup>g</sup>Fisher's exact test (all other <italic>P</italic>-values show Pearson Ï<sup>2</sup>).</p></fn></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="s3b">
                <title>Study diagnosis</title>
                <p>The point prevalence of HF was 22.8% [<italic>n</italic> =91, 95% confidence interval (CI) 18.8â27.2%]; of these, 62.7% (<italic>n</italic> =57, 95% CI 59.6â66.5%) had HFpEF and 37.3% had LVSD (<italic>n</italic> =34, 95% CI 34.8â40.5%). A further three patients had LVSD without clinical signs of HF. In total, 34 (8.5%, 95% CI 6.0â11.7%) were diagnosed with LVSD, categorized as: mild, 19 (56%); moderate, 9 (27%); or severe, 6 (18%). Participants with and without LVSD were broadly similar in terms of age and sex (<italic>TableÂ <xref ref-type="table" rid="HFS165TB2">2</xref></italic>).</p>
                <p>Participants with LVSD were more likely to have orthopnoea, a raised JVP, lung crackles, abnormal ECG, and mitral regurgitation (see <italic>TableÂ <xref ref-type="table" rid="HFS165TB3">3</xref></italic> for a complete list of clinical symptoms and signs). HFpEF additionally featured raised levels of peripheral oedema. The number qualifying for HFpEF according to ESC criteria<sup><xref ref-type="bibr" rid="HFS165C19">19</xref></sup> of E/E' (8â15) and BNP &gt;200 pg/mL (or NT-proBNP &gt;220 pg/mL) was 11 residents (19%); the remainder (<italic>n</italic> =46) had an E/E' of &gt;15.
<table-wrap id="HFS165TB3" position="float"><label>TableÂ 3</label><caption><p>Heart failure-related characteristics of participants by (study-determined) heart failure status</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">No HF (A), <italic>n</italic> = 308</th><th align="left" rowspan="1" colspan="1">LVSD (B), <italic>n</italic> = 34</th><th align="left" rowspan="1" colspan="1">HFpEF (C), <italic>n</italic> = 57</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value (A vs. B)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value (A vs. C)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Symptoms</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">âOrthopnea</td><td rowspan="1" colspan="1">36 (11.7%)</td><td rowspan="1" colspan="1">10 (29.4%)</td><td rowspan="1" colspan="1">17 (29.8%)</td><td rowspan="1" colspan="1">0.027<sup>a</sup></td><td rowspan="1" colspan="1">0.003</td></tr><tr><td rowspan="1" colspan="1">Signs and echo findings</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">âRaised JVP<sup>b</sup></td><td rowspan="1" colspan="1">25 (8.1%)</td><td rowspan="1" colspan="1">7 (20.6%)</td><td rowspan="1" colspan="1">10 (17.5%)</td><td rowspan="1" colspan="1">0.054<sup>a</sup></td><td rowspan="1" colspan="1">0.058</td></tr><tr><td rowspan="1" colspan="1">âLung crackles<sup>c</sup></td><td rowspan="1" colspan="1">52 (16.9%)</td><td rowspan="1" colspan="1">12 (35.3%)</td><td rowspan="1" colspan="1">19 (33.3%)</td><td rowspan="1" colspan="1">0.031<sup>a</sup></td><td rowspan="1" colspan="1">0.012</td></tr><tr><td rowspan="1" colspan="1">âOedema<sup>d</sup></td><td rowspan="1" colspan="1">125 (40.6%)</td><td rowspan="1" colspan="1">19 (55.9%)</td><td rowspan="1" colspan="1">39 (68.4%)</td><td rowspan="1" colspan="1">0.487</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">âSystolic BP<sup>e</sup></td><td rowspan="1" colspan="1">131 (Â±22)</td><td rowspan="1" colspan="1">131 (Â±26)</td><td rowspan="1" colspan="1">135 (Â±25)</td><td rowspan="1" colspan="1">0.896</td><td rowspan="1" colspan="1">0.141</td></tr><tr><td rowspan="1" colspan="1">âDiastolic BP<sup>f</sup></td><td rowspan="1" colspan="1">72 (Â±10)</td><td rowspan="1" colspan="1">71 (Â±13)</td><td rowspan="1" colspan="1">68 (Â±10)</td><td rowspan="1" colspan="1">0.213</td><td rowspan="1" colspan="1">0.643</td></tr><tr><td rowspan="1" colspan="1">âHeart rate</td><td rowspan="1" colspan="1">72 (Â±12)</td><td rowspan="1" colspan="1">75 (Â±13)</td><td rowspan="1" colspan="1">74 (Â±13)</td><td rowspan="1" colspan="1">0.630</td><td rowspan="1" colspan="1">0.541</td></tr><tr><td rowspan="1" colspan="1">âRespiratory rate<sup>g</sup></td><td rowspan="1" colspan="1">18 (Â±4)</td><td rowspan="1" colspan="1">19 (Â±4)</td><td rowspan="1" colspan="1">18 (Â±4)</td><td rowspan="1" colspan="1">0.293</td><td rowspan="1" colspan="1">0.374</td></tr><tr><td rowspan="1" colspan="1">âAbnormal ECG</td><td rowspan="1" colspan="1">153 (49.7%)</td><td rowspan="1" colspan="1">29 (85.3%)</td><td rowspan="1" colspan="1">35 (61.4%)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.157</td></tr><tr><td rowspan="1" colspan="1">âAbnormal diastolic function</td><td rowspan="1" colspan="1">85 (27.6%)</td><td rowspan="1" colspan="1">14 (41.2%)</td><td rowspan="1" colspan="1">56 (98.2%)</td><td rowspan="1" colspan="1">0.334</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">âEjection fraction %<sup>h</sup></td><td rowspan="1" colspan="1">63.9 (Â±8.0)</td><td rowspan="1" colspan="1">39.0 (Â±7.1)</td><td rowspan="1" colspan="1">56.0 (Â±2.2)</td><td rowspan="1" colspan="1">0.191</td><td rowspan="1" colspan="1">0.825</td></tr><tr><td rowspan="1" colspan="1">âSevere aortic regurgitation<sup>i</sup></td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">âSevere aortic stenosis</td><td rowspan="1" colspan="1">3 (1.0%)</td><td rowspan="1" colspan="1">2 (5.9%)</td><td rowspan="1" colspan="1">2 (3.5%)</td><td rowspan="1" colspan="1">0.113<sup>a</sup></td><td rowspan="1" colspan="1">0.263<sup>a</sup></td></tr><tr><td rowspan="1" colspan="1">âSevere mitral regurgitation<sup>j</sup></td><td rowspan="1" colspan="1">2 (0.6%)</td><td rowspan="1" colspan="1">1 (2.9%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td rowspan="1" colspan="1">âSevere mitral stenosis<sup>k</sup></td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><fn><p>BP, blood pressure; ECG, electorcardiogram; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; JVP, jugular venous presure; LVSD, left ventricular systolic dysfunction.</p></fn><fn><p><sup>a</sup>Fisher's exact test (all other <italic>P</italic>-values show Pearson Ï<sup>2</sup>).</p></fn><fn><p><sup>b</sup>JVP measurement was available for 384 (96.2%) residents.</p></fn><fn><p><sup>c</sup>Lung assessment was available for 398 (99.7%) residents.</p></fn><fn><p><sup>d</sup>Oedema assessment was available for 397 (99.4%) residents.</p></fn><fn><p><sup>e</sup>Systolic BP measurement was available for 398 (99.7%) residents.</p></fn><fn><p><sup>f</sup>Diastolic BP measurement was available for 395 (98.9%) residents.</p></fn><fn><p><sup>g</sup>Respiratory rate was available for 398 (99.7%) residents.</p></fn><fn><p><sup>h</sup>Ejection fraction % was available for 17 (4%) residents.</p></fn><fn><p><sup>i</sup>Aortic regurgitation measurement was available for 366 (91.7%) residents.</p></fn><fn><p><sup>j</sup>Mitral regurgitation measurement was available for 385 (96.5%) residents.</p></fn><fn><p><sup>k</sup>Mitral stenosis measurement was available for 396 (99.2%) residents. All other measurements were available for the full cohort (<italic>n</italic> = 399).</p></fn></table-wrap-foot></table-wrap></p>
                <p>The NYHA classification was not a reliable indicator of systolic dysfunction; participants with an assessment of NYHA class IV were classified as having mild or moderate LVSD, while those with NYHA class I had mild, moderate, or severe LVSD. Study assessment of NYHA classification was not possible in 101 participants (25%) due to immobility; the remainder were ambulant. A total of 129 (32%) residents had an elevated respiratory rate (&gt;20 breaths/min), and 183 (49%) had peripheral oedema (mild or moderate); 59 (15%) residents had both, and, of these, four residents also had a raised BNP (&gt;400 pg/mL). Of the 59 symptomatic residents with an elevated respiratory rate and peripheral oedema, 20 (34%) had HF, of which 5 had an existing record of HF and15 were newly diagnosed. Of the four residents with these signs plus a raised BNP, three had HF, of which one was newly diagnosed.</p>
                <p>The acceptability of the diagnostic assessment by residents was high: four (1%) residents reported they would decline a request to repeat parts of the assessments, two found the echocardiogram procedure uncomfortable, and two reported they would decline further blood tests. There were only four unsuccessful venepuncture attempts in the 405 participants.</p>
              </sec>
              <sec id="s3c">
                <title>Comparison of study and recorded diagnoses</title>
                <p>Medical records did not specify the type or severity of HF in 99% of cases. Up to 50% of confirmed LVSD was previously diagnosed and noted in primary care, but only 12% was recorded in care facility notes. HFpEF was previously undiagnosed in â¼90% of cases (<italic>TableÂ <xref ref-type="table" rid="HFS165TB4">4</xref></italic>). Of 71 cases recorded either in general practice notes or in a HF register, 17 (24%) were confirmed as either LVSD or HFpEF.
<table-wrap id="HFS165TB4" position="float"><label>TableÂ 4</label><caption><p>Comparison of study findings from medical and health care records</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">General practice notes</th><th align="left" rowspan="1" colspan="1">General practice HF register</th><th align="left" rowspan="1" colspan="1">Care facility notes</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">LVSD (<italic>n</italic> = 34)</td><td rowspan="1" colspan="1">Confirmed<sup>a</sup></td><td rowspan="1" colspan="1">15 (44.1%)</td><td rowspan="1" colspan="1">16 (47.1%)</td><td rowspan="1" colspan="1">4 (11.8%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">New<sup>b</sup></td><td rowspan="1" colspan="1">19 (55.9%)</td><td rowspan="1" colspan="1">18 (52.9%)</td><td rowspan="1" colspan="1">30 (88.2%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Not confirmed<sup>c</sup></td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">13</td></tr><tr><td rowspan="1" colspan="1">HFpEF (<italic>n</italic> = 57)</td><td rowspan="1" colspan="1">Confirmed</td><td rowspan="1" colspan="1">3 (5.3%)</td><td rowspan="1" colspan="1">6 (10.5%)</td><td rowspan="1" colspan="1">3 (5.3%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">New</td><td rowspan="1" colspan="1">54 (94.7%)</td><td rowspan="1" colspan="1">51 (89.5%)</td><td rowspan="1" colspan="1">54 (94.7%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Not confirmed</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">57</td><td rowspan="1" colspan="1">14</td></tr></tbody></table><table-wrap-foot><fn><p>HF, heart failure; HFpEF, heart failure with preserved ejection fraction; LVSD, left ventricular systolic dysfunction.</p></fn><fn><p><sup>a</sup>Study finding and health record agree.</p></fn><fn><p><sup>b</sup>LVSD found in study but not in health record.</p></fn><fn><p><sup>c</sup>LVSD found in health record but not confirmed by study.</p></fn></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="s3d">
                <title>Study diagnosis, recorded co-morbidity, and clinical care</title>
                <p>According to general practice records, the three most common co-morbidities were hypertension (48%), osteoarthritis (36%), and cognitive impairment (30%) (<italic>TableÂ <xref ref-type="table" rid="HFS165TB5">5</xref></italic>). Only eight (2%) participants had no record of any co-morbidity; none of these had HF. Participants had a mean of three co-morbidities (range 1â7, SD 1.4) (<italic>TableÂ <xref ref-type="table" rid="HFS165TB5">5</xref></italic>). The number of co-morbidities was not significantly different between those with and without HF (<italic>P</italic> =0.641). Participants with LVSD were more likely to have a previous myocardial infarction or atrial fibrillation and to have been prescribed beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, diuretics, and warfarin (<italic>TableÂ <xref ref-type="table" rid="HFS165TB5">5</xref></italic>). Nearly 50% of these patients were receiving an ACE inhibitor or beta-blocker. Of 80 patients with any pre-existing record of HF, 36% were receiving an ACE inhibitor and 43% beta-blockers (<italic>TableÂ <xref ref-type="table" rid="HFS165TB6">6</xref></italic>).
<table-wrap id="HFS165TB5" position="float"><label>TableÂ 5</label><caption><p>Co-morbidities and drug prescriptions by study-determined heart failure status</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char=" " span="1"/><col align="char" char=" " span="1"/><col align="char" char=" " span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="left" rowspan="1" colspan="1">No HF (A), <italic>n</italic> = 308</th><th align="left" rowspan="1" colspan="1">LVSD (B), <italic>n</italic> = 34</th><th align="left" rowspan="1" colspan="1">HFpEF (C), <italic>n</italic> = 57</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value (A vs. B)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value (A vs. C)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Co-morbidities</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">âMyocardial infarction</td><td rowspan="1" colspan="1">21 (6.8%)</td><td rowspan="1" colspan="1">7 (20.6%)</td><td rowspan="1" colspan="1">4 (7.0%)</td><td rowspan="1" colspan="1">0.012*</td><td rowspan="1" colspan="1">0.507*</td></tr><tr><td rowspan="1" colspan="1">âIschaemic heart disease</td><td rowspan="1" colspan="1">54 (17.5%)</td><td rowspan="1" colspan="1">6 (17.6%)</td><td rowspan="1" colspan="1">14 (24.6%)</td><td rowspan="1" colspan="1">0.549*</td><td rowspan="1" colspan="1">0.143*</td></tr><tr><td rowspan="1" colspan="1">âHypertension</td><td rowspan="1" colspan="1">151 (49.0%)</td><td rowspan="1" colspan="1">16 (47.1%)</td><td rowspan="1" colspan="1">26 (45.6%)</td><td rowspan="1" colspan="1">0.508*</td><td rowspan="1" colspan="1">0.380*</td></tr><tr><td rowspan="1" colspan="1">âAtrial fibrillation</td><td rowspan="1" colspan="1">45 (14.6%)</td><td rowspan="1" colspan="1">14 (41.2%)</td><td rowspan="1" colspan="1">8 (14.0%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">0.351*</td></tr><tr><td rowspan="1" colspan="1">âValvular heart disease</td><td rowspan="1" colspan="1">9 (2.9%)</td><td rowspan="1" colspan="1">4 (11.8%)</td><td rowspan="1" colspan="1">3 (5.3%)</td><td rowspan="1" colspan="1">0.127*</td><td rowspan="1" colspan="1">0.364*</td></tr><tr><td rowspan="1" colspan="1">âMitral valvular heart disease</td><td rowspan="1" colspan="1">5 (1.6%)</td><td rowspan="1" colspan="1">1 (2.9%)</td><td rowspan="1" colspan="1">2 (3.5%)</td><td rowspan="1" colspan="1">0.513*</td><td rowspan="1" colspan="1">0.320*</td></tr><tr><td rowspan="1" colspan="1">âAortic valvular heart disease</td><td rowspan="1" colspan="1">5 (1.6%)</td><td rowspan="1" colspan="1">1 (2.9%)</td><td rowspan="1" colspan="1">2 (3.5%)</td><td rowspan="1" colspan="1">0.513*</td><td rowspan="1" colspan="1">0.320*</td></tr><tr><td rowspan="1" colspan="1">âDiabetes</td><td rowspan="1" colspan="1">59 (19.2%)</td><td rowspan="1" colspan="1">7 (20.6%)</td><td rowspan="1" colspan="1">9 (15.8%)</td><td rowspan="1" colspan="1">0.464*</td><td rowspan="1" colspan="1">0.337*</td></tr><tr><td rowspan="1" colspan="1">âCOPD</td><td rowspan="1" colspan="1">25 (8.1%)</td><td rowspan="1" colspan="1">4 (11.8%)</td><td rowspan="1" colspan="1">11 (19.3%)</td><td rowspan="1" colspan="1">0.451*</td><td rowspan="1" colspan="1">0.016*</td></tr><tr><td rowspan="1" colspan="1">âOsteoarthritis</td><td rowspan="1" colspan="1">105 (34.1%)</td><td rowspan="1" colspan="1">15 (44.1%)</td><td rowspan="1" colspan="1">22 (38.6%)</td><td rowspan="1" colspan="1">0.184*</td><td rowspan="1" colspan="1">0.355*</td></tr><tr><td rowspan="1" colspan="1">âCognitive impairment</td><td rowspan="1" colspan="1">102 (33.1%)</td><td rowspan="1" colspan="1">10 (29.4%)</td><td rowspan="1" colspan="1">9 (15.8%)</td><td rowspan="1" colspan="1">0.538*</td><td rowspan="1" colspan="1">0.006*</td></tr><tr><td rowspan="1" colspan="1">Prescribed drugs</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">âBeta-blocker</td><td rowspan="1" colspan="1">56 (18.2%)</td><td rowspan="1" colspan="1">16 (47.1%)</td><td rowspan="1" colspan="1">11 (19.3%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">0.460*</td></tr><tr><td rowspan="1" colspan="1">âACE inhibitor</td><td rowspan="1" colspan="1">58 (18.8%)</td><td rowspan="1" colspan="1">15 (44.1%)</td><td rowspan="1" colspan="1">15 (26.3%)</td><td rowspan="1" colspan="1">0.021</td><td rowspan="1" colspan="1">0.939</td></tr><tr><td rowspan="1" colspan="1">âAngiotensin receptor blocker</td><td rowspan="1" colspan="1">18 (5.8%)</td><td rowspan="1" colspan="1">1 (2.9%)</td><td rowspan="1" colspan="1">5 (8.8%)</td><td rowspan="1" colspan="1">0.373*</td><td rowspan="1" colspan="1">0.248*</td></tr><tr><td rowspan="1" colspan="1">âCalcium chanel blocker</td><td rowspan="1" colspan="1">56 (18.2%)</td><td rowspan="1" colspan="1">5 (14.7%)</td><td rowspan="1" colspan="1">17 (29.8%)</td><td rowspan="1" colspan="1">0.313*</td><td rowspan="1" colspan="1">0.030*</td></tr><tr><td rowspan="1" colspan="1">âDiuretic</td><td rowspan="1" colspan="1">85 (27.6%)</td><td rowspan="1" colspan="1">19 (55.9%)</td><td rowspan="1" colspan="1">24 (42.1%)</td><td rowspan="1" colspan="1">0.002*</td><td rowspan="1" colspan="1">0.057*</td></tr><tr><td rowspan="1" colspan="1">âStatin</td><td rowspan="1" colspan="1">117 (38.0%)</td><td rowspan="1" colspan="1">17 (50.0%)</td><td rowspan="1" colspan="1">27 (47.4%)</td><td rowspan="1" colspan="1">0.155*</td><td rowspan="1" colspan="1">0.154*</td></tr><tr><td rowspan="1" colspan="1">âDigoxin</td><td rowspan="1" colspan="1">24 (7.8%)</td><td rowspan="1" colspan="1">5 (14.7%)</td><td rowspan="1" colspan="1">2 (3.5%)</td><td rowspan="1" colspan="1">0.111*</td><td rowspan="1" colspan="1">0.150*</td></tr><tr><td rowspan="1" colspan="1">âAntiplatelet</td><td rowspan="1" colspan="1">159 (51.6%)</td><td rowspan="1" colspan="1">24 (70.6%)</td><td rowspan="1" colspan="1">24 (42.1%)</td><td rowspan="1" colspan="1">0.215*</td><td rowspan="1" colspan="1">0.099*</td></tr><tr><td rowspan="1" colspan="1">âSpironolactone</td><td rowspan="1" colspan="1">7 (2.3%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1">0.487*</td><td rowspan="1" colspan="1">0.680*</td></tr><tr><td rowspan="1" colspan="1">âBronchodilators</td><td rowspan="1" colspan="1">46 (14.9%)</td><td rowspan="1" colspan="1">7 (20.6%)</td><td rowspan="1" colspan="1">16 (28.1%)</td><td rowspan="1" colspan="1">0.370*</td><td rowspan="1" colspan="1">0.020*</td></tr><tr><td rowspan="1" colspan="1">âWarfarin</td><td rowspan="1" colspan="1">8 (2.6%)</td><td rowspan="1" colspan="1">4 (11.8%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1">0.018*</td><td rowspan="1" colspan="1">0.423*</td></tr><tr><td rowspan="1" colspan="1">âNSAIDs</td><td rowspan="1" colspan="1">25 (8.1%)</td><td rowspan="1" colspan="1">1 (2.9%)</td><td rowspan="1" colspan="1">7 (12.3%)</td><td rowspan="1" colspan="1">0.203*</td><td rowspan="1" colspan="1">0.174*</td></tr></tbody></table><table-wrap-foot><fn><p>ACE, angiotensin-converting enzyme; COPD, chronic obstructive pulmonary disease; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; LVSD, left ventricular systolic dysfunction; NSAIDs, non-steroidal anti-inflammatory drugs.</p></fn><fn><p>*Fisher's Exact Test (all other <italic>p</italic> values show Pearson Chi-Square).</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="HFS165TB6" position="float"><label>TableÂ 6</label><caption><p>Rates of angiotensin-converting enzyme, beta-blocker, and spironolactone prescribing in patients with left ventricular systolic dysfunction, categorized by study findings</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char=" " span="1"/><col align="char" char=" " span="1"/><col align="char" char=" " span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Any HF record<sup>a</sup></th><th align="left" rowspan="1" colspan="1">ACE inhibitor<sup>b</sup></th><th align="left" rowspan="1" colspan="1">Beta-blockers<sup>b</sup></th><th align="left" rowspan="1" colspan="1">Spironolactone<sup>b</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">LVSD (<italic>n</italic> = 34)</td><td rowspan="1" colspan="1">Confirmed</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">10 (53%)</td><td rowspan="1" colspan="1">11 (58%)</td><td rowspan="1" colspan="1">0 (0%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">New</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">5 (33%)</td><td rowspan="1" colspan="1">5 (33%)</td><td rowspan="1" colspan="1">0 (0%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Not confirmed</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">19 (31%)</td><td rowspan="1" colspan="1">23 (38%)</td><td rowspan="1" colspan="1">3 (5%)</td></tr></tbody></table><table-wrap-foot><fn><p>ACE, angiotensin-converting enzyme; HF, heart failure; LVSD, left ventricular systolic dysfunction.</p></fn><fn><p><sup>a</sup>A heart failure record, specified or unspecified in general practice notes, register, or care facility records.</p></fn><fn><p><sup>b</sup>Any dose.</p></fn></table-wrap-foot></table-wrap></p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>In our large, institution-based study of older people, we report that HF was diagnosed in almost a quarter of residents, two-thirds of whom had HFpEF. The prevalence of HF was substantially higher than in community populations. Most cases of HF were previously undiagnosed, and three-quarters of previously recorded cases were not confirmed. Symptoms and signs typically associated with HF such as leg oedema and breathlesness appear to have little clinical utility in this population. In summary, these findings indicate a HF and HFpEF burden that is substantially higher than previously thought.</p>
              <sec id="s4a">
                <title>Previous studies</title>
                <p>Four studies have previously estimated the prevalence of HF in long-term care, varying from 23% to 42%.<sup><xref ref-type="bibr" rid="HFS165C18">18</xref>,<xref ref-type="bibr" rid="HFS165C24">24</xref>,<xref ref-type="bibr" rid="HFS165C34">34</xref>,<xref ref-type="bibr" rid="HFS165C35">35</xref></sup> These studies were small (100â150 residents), with the exception of one large US study (nearly 3000 residents).<sup><xref ref-type="bibr" rid="HFS165C28">28</xref></sup> Participants' mean age and gender distributions were similar to those of the cohort in this study, but definitions of HF and methods of diagnosis varied. Most studies relied on medical records to identify HF, with no details about operational definitions; only one prevalence study<sup><xref ref-type="bibr" rid="HFS165C16">16</xref></sup> used echocardiography to assess and define the presence of LVSD. For comparison, the prevalence of undifferentiated HF based on medical records (a HF register) in our study was 32%.</p>
                <p>Recent evidence suggests potential prognostic benefits of ACE inhibitors for patients with HFpEF.<sup><xref ref-type="bibr" rid="HFS165C36">36</xref></sup> However, findings from this study indicate a tendency towards the use of diuretics for this group. The high incidence of HFpEF detected suggests the need for further research in this population, in order to establish clear guidelines for treatment;<sup><xref ref-type="bibr" rid="HFS165C36">36</xref>,<xref ref-type="bibr" rid="HFS165C37">37</xref></sup> this is borne out in the latest ESC guidelines.<sup><xref ref-type="bibr" rid="HFS165C38">38</xref></sup></p>
              </sec>
              <sec id="s4b">
                <title>Implications of study findings</title>
                <p>The findings of this study have implications for practice internationally and challenge the current focus on diagnosis and treatment of undifferentiated HF in this population: high levels of misdiagnosis, missed diagnosis, and the lack of evidence-based treatment found in this study might be explained in part by this lack of differentiation. In this study, HF was diagnosed in almost a quarter (22.8%) of participants. The prevalence of LVSD was lower than anticipated, while rates of asymptomatic LVSD reflect international data.<sup><xref ref-type="bibr" rid="HFS165C20">20</xref></sup> However, the study found high rates of HFpEF: this is the first known prevalence study to report HFpEF and LVSD as clearly defined subgroupings of HF in this population. Half of the HF cases diagnosed within the study were previously undiagnosed, while three-quarters of previously recorded cases appeared misdiagnosed (not confirmed by the study). Baseline demographic characteristics of participants and non-participants were almost identical and reflect other long-term care populations in different socio-economic groups and different countries with alternative service provision models.<sup><xref ref-type="bibr" rid="HFS165C18">18</xref>,<xref ref-type="bibr" rid="HFS165C24">24</xref>,<xref ref-type="bibr" rid="HFS165C34">34</xref>,<xref ref-type="bibr" rid="HFS165C35">35</xref></sup> Findings are therefore likely to be generalizable nationally and internationally. The cohort did not include patients from ethnic minorities; these patients are much less commonly represented in care home populations for cultural reasons. Half of study-determined cases of LVSD (17 of 34) and 6 of 57 cases of HFpEF were previously recorded as undifferentiated HF in general practice records. Previous studies have limited their examination of care provision to records held by healthcare professionals outside of long-term care facilities. Our study supports international evidence that an accurate diagnosis may be missed in up to half of cases.<sup><xref ref-type="bibr" rid="HFS165C18">18</xref>,</sup><sup><xref ref-type="bibr" rid="HFS165C21">21</xref>â<xref ref-type="bibr" rid="HFS165C23">23</xref></sup> Difficulties diagnosing HF, organizing care across a wide range of care facilities, and allocating scarce health service resources can mean that important health needs of the older population in care are unmet. Based on these data, a review of current diagnostic processes within long-term care seems timely.</p>
              </sec>
              <sec id="s4c">
                <title>Strengths and limitations</title>
                <p>Long-term care facilities proved a challenging environment, which led to some limitations for this research. As a condition of research access into care facilities, staff determined in part which residents were invited to participate. Thus participation within the study was filtered at three levels, by staff, by relatives, and by the residents themselves. Limited cognitive capacity was common, and a consultee declaration was required in 66% of participants. While 35% of eligible (non-excluded) residents participated, individual reasons for non-participation could not be determined within the selection process. A comparison of participants and non-participants reveals similarity in age, gender, and ethnicity. Study assessment tools, including the AMTS and EQ-5D, were carefully selected to avoid lengthy assessment times. A very high proportion (399/405, 98.5%) of recruited participants completed assessments, pointing to the acceptability of the assessments, including portable echocardiography, and the generalizability of findings.</p>
                <p>There were difficulties assessing NYHA class and other symptoms and signs in this sedentary population; the lack of correlation between NYHA classification and LVSD severity, and between LVSD and HFpEF raises questions about its utility in the study population. Symptoms suggestive of HF such as oedema and dyspnoea were poor predictors of HF in this study. These were as common in participants without HF as in those with HF, and appear to have little diagnostic utility in this population. The routine introduction of portable echocardiography in care facilities might be essential to accurate diagnosis; this reflects the views of others about how best to achieve accurate diagnosis in older people.<sup><xref ref-type="bibr" rid="HFS165C12">12</xref></sup></p>
                <p>This study examined long-term care facility records which are used on a day to day basis (including prescriptions and co-morbidities) for this group and found them to be incomplete. Access to general practice and care facility records provided information about diagnoses and treatment but not the rationale behind decisions or relevant contraindications to medications; thus, the reasons for treatment decisions remain unknown.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="s5">
              <title>Conclusion</title>
              <p>In our large study of older people in long-term care, HF was diagnosed in almost a quarter of residents, two-thirds of whom had HFpEF. The prevalence of HF was substantially higher than in community populations. Symptoms and signs typically associated with HF such as leg oedema and breathlessness appear to have little clinical utility in this population. Findings suggest that this population is not routinely receiving evidence-based diagnosis; screening for HF was feasible and acceptable in this study. This challenges the current organization of diagnostic services for older people in care, which needs to be addressed at national and international levels.</p>
              <sec id="s5a">
                <title>Funding</title>
                <p>This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0407-13309). The views expressed are those of the authors and not necessarily those of the NHS, the <funding-source>NIHR</funding-source> or the Department of Health.</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgements</title>
              <p>The authors wish to thank Mrs Rebecca Maier and Miss Jennifer Wilkinson of the Durham Clinical Trials Unit for their roles in overseeing research governance processes and data management. We thank Dr Novin Manshani, Dr David Hodges, and Ms Jan Hart for their roles in study conduct.</p>
              <p><bold>Conflict of interest:</bold> None declared.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="HFS165C1">
                <label>1</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aronow</surname>
                      <given-names>WS</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical causes of death of 2372 older persons in a nursing home during 15-year follow-up</article-title>
                  <source>J Am Med Dir Assoc</source>
                  <year>2000</year>
                  <volume>1</volume>
                  <fpage>95</fpage>
                  <lpage>96</lpage>
                  <pub-id pub-id-type="pmid">12818019</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C2">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gambassi</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Forman</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Lapane</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Mor</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Sgadari</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lipsitz</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Bernabei</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <collab>The SAGE Study Group</collab>
                  <article-title>Management of heart failure among very old persons living in long-term care: has the voice of trials spread</article-title>
                  <source>Am Heart J</source>
                  <year>2000</year>
                  <volume>139</volume>
                  <fpage>85</fpage>
                  <lpage>93</lpage>
                  <pub-id pub-id-type="pmid">10618567</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C3">
                <label>3</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Weaver</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Allman</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>DeLong</surname>
                      <given-names>JF</given-names>
                    </name>
                    <name>
                      <surname>Aronow</surname>
                      <given-names>WS</given-names>
                    </name>
                  </person-group>
                  <article-title>The quality of care of nursing home residents hospitalized with heart failure</article-title>
                  <source>J Am Geriatr Soc</source>
                  <year>2002</year>
                  <volume>50</volume>
                  <fpage>1831</fpage>
                  <lpage>1836</lpage>
                  <pub-id pub-id-type="pmid">12410902</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C4">
                <label>4</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sloane</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Gruber-Baldini</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Zimmerman</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Roth</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Watson</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Boustani</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Magaziner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hebel</surname>
                      <given-names>JR</given-names>
                    </name>
                  </person-group>
                  <article-title>Medication undertreatment in assisted living settings</article-title>
                  <source>Arch Intern Med</source>
                  <year>2004</year>
                  <volume>164</volume>
                  <fpage>2031</fpage>
                  <lpage>2037</lpage>
                  <pub-id pub-id-type="pmid">15477439</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C5">
                <label>5</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shah</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Carey</surname>
                      <given-names>IM</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>DeWilde</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Cook</surname>
                      <given-names>DG</given-names>
                    </name>
                  </person-group>
                  <article-title>Quality of chronic disease care for older people in care homes and the community on a primary care pay for performance system: retrospective study</article-title>
                  <source>BMJ</source>
                  <year>2001</year>
                  <volume>342</volume>
                  <fpage>d912</fpage>
                  <pub-id pub-id-type="pmid">21385803</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C6">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fried</surname>
                      <given-names>LP</given-names>
                    </name>
                  </person-group>
                  <article-title>Establishing benchmarks for quality care for an aging population: caring for vulnerable older adults</article-title>
                  <source>Ann Intern Med</source>
                  <year>2003</year>
                  <volume>139</volume>
                  <fpage>784</fpage>
                  <lpage>786</lpage>
                  <pub-id pub-id-type="pmid">14597464</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C7">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arroll</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Doughty</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Andersen</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Investigation and management of congestive heart failure</article-title>
                  <source>BMJ</source>
                  <year>2010</year>
                  <volume>341</volume>
                  <fpage>c3657</fpage>
                  <pub-id pub-id-type="pmid">20630951</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C8">
                <label>8</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Hays</surname>
                      <given-names>CI</given-names>
                    </name>
                  </person-group>
                  <article-title>DEFEAT Heart Failure: assessment and management of heart failure in nursing homes made easy</article-title>
                  <source>J Am Med Dir Assoc</source>
                  <year>2008</year>
                  <volume>9</volume>
                  <fpage>383</fpage>
                  <lpage>389</lpage>
                  <pub-id pub-id-type="pmid">18585640</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C9">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bowman</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Whistler</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ellerby</surname>
                      <given-names>MA</given-names>
                    </name>
                  </person-group>
                  <article-title>National census of care home residents</article-title>
                  <source>Age Ageing</source>
                  <year>2004</year>
                  <volume>33</volume>
                  <fpage>561</fpage>
                  <lpage>566</lpage>
                  <pub-id pub-id-type="pmid">15308458</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C10">
                <label>10</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gure</surname>
                      <given-names>TR</given-names>
                    </name>
                    <name>
                      <surname>Kabeto</surname>
                      <given-names>MU</given-names>
                    </name>
                    <name>
                      <surname>Blaum</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Langa</surname>
                      <given-names>KM</given-names>
                    </name>
                  </person-group>
                  <article-title>Degree of disability and patterns of caregiving among older Americans with congestive heart failure</article-title>
                  <source>J Gen Intern Med</source>
                  <year>2008</year>
                  <volume>23</volume>
                  <fpage>70</fpage>
                  <lpage>76</lpage>
                  <pub-id pub-id-type="pmid">18030537</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C11">
                <label>11</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oudejans</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Mosterd</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bloemen</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Valk</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>van Velzen</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Wielders</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Zuithoff</surname>
                      <given-names>NP</given-names>
                    </name>
                    <name>
                      <surname>Rutten</surname>
                      <given-names>FH</given-names>
                    </name>
                    <name>
                      <surname>Hoes</surname>
                      <given-names>AW</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2011</year>
                  <volume>13</volume>
                  <fpage>518</fpage>
                  <lpage>527</lpage>
                  <pub-id pub-id-type="pmid">21422000</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C12">
                <label>12</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Manzano</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Escobar</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Cleland</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Flather</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Diagnosis of elderly patients with heart failure</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2012</year>
                  <volume>14</volume>
                  <fpage>1097</fpage>
                  <lpage>1103</lpage>
                  <pub-id pub-id-type="pmid">22771845</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C13">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mogensen</surname>
                      <given-names>UM</given-names>
                    </name>
                    <name>
                      <surname>ErsbÃ¸ll</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Andersen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Andersson</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Hassager</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Torp-Pedersen</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Gustafsson</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>KÃ¸ber</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2011</year>
                  <volume>13</volume>
                  <fpage>1216</fpage>
                  <lpage>1223</lpage>
                  <pub-id pub-id-type="pmid">21896536</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C14">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fuat</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hungin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study</article-title>
                  <source>BMJ</source>
                  <year>2003</year>
                  <volume>326</volume>
                  <fpage>196</fpage>
                  <lpage>200</lpage>
                  <pub-id pub-id-type="pmid">12543836</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C15">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rutten</surname>
                      <given-names>FH</given-names>
                    </name>
                    <name>
                      <surname>Grobbe</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Hoes</surname>
                      <given-names>AW</given-names>
                    </name>
                  </person-group>
                  <article-title>Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2003</year>
                  <volume>5</volume>
                  <fpage>337</fpage>
                  <lpage>344</lpage>
                  <pub-id pub-id-type="pmid">12798832</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C16">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cowie</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Struthers</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Wood</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Coats</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Poole-Wilson</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Sutton</surname>
                      <given-names>GC</given-names>
                    </name>
                  </person-group>
                  <article-title>Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care</article-title>
                  <source>Lancet</source>
                  <year>1997</year>
                  <volume>350</volume>
                  <fpage>1349</fpage>
                  <lpage>1353</lpage>
                  <pub-id pub-id-type="pmid">9365448</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C17">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aronow</surname>
                      <given-names>WS</given-names>
                    </name>
                    <name>
                      <surname>Rich</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Goodlin</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Birkner</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Feller</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Aban</surname>
                      <given-names>IB</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>LG</given-names>
                    </name>
                    <name>
                      <surname>Bearden</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Allman</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure</article-title>
                  <source>J Am Med Dir Assoc</source>
                  <year>2012</year>
                  <volume>13</volume>
                  <fpage>448</fpage>
                  <lpage>52</lpage>
                  <pub-id pub-id-type="pmid">21982687</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C18">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barents</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>van der Horst</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Voors</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hillege</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Muskiet</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>de Jongste</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence and misdiagnosis of chronic heart failure in nursing home residents: the role of B-type natruiretic peptides</article-title>
                  <source>Neth Heart J</source>
                  <year>2008</year>
                  <volume>16</volume>
                  <fpage>123</fpage>
                  <lpage>128</lpage>
                  <pub-id pub-id-type="pmid">18427636</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C19">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Paulus</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Tschope</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Sanderson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Paulus</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>TschÃ¶pe</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Sanderson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Rusconi</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Flachskampf</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Rademakers</surname>
                      <given-names>FE</given-names>
                    </name>
                    <name>
                      <surname>Marino</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Smiseth</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>De Keulenaer</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Leite-Moreira</surname>
                      <given-names>AF</given-names>
                    </name>
                    <name>
                      <surname>BorbÃ©ly</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ãdes</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Handoko</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Heymans</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pezzali</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Pieske</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Dickstein</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Fraser</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Brutsaert</surname>
                      <given-names>DL</given-names>
                    </name>
                  </person-group>
                  <article-title>How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology</article-title>
                  <source>Eur Heart J</source>
                  <year>2007</year>
                  <volume>28</volume>
                  <fpage>2539</fpage>
                  <lpage>2550</lpage>
                  <pub-id pub-id-type="pmid">17428822</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C20">
                <label>20</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mureddu</surname>
                      <given-names>GF</given-names>
                    </name>
                    <name>
                      <surname>Agabiti</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Rizzello</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Forastiere</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Latini</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cesaroni</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Masson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Cacciatore</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Colivicchi</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Uguccioni</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Perucci</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Boccanelli</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <collab>on behalf of the PREDICTOR Study Group</collab>
                  <article-title>Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2012</year>
                  <volume>14</volume>
                  <fpage>718</fpage>
                  <lpage>729</lpage>
                  <pub-id pub-id-type="pmid">22562498</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C21">
                <label>21</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khand</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Shaw</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gemmel</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Cleland</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2005</year>
                  <volume>7</volume>
                  <fpage>792</fpage>
                  <lpage>797</lpage>
                  <pub-id pub-id-type="pmid">16054867</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C22">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davies</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hobbs</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Kenkre</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Roalfe</surname>
                      <given-names>AK</given-names>
                    </name>
                    <name>
                      <surname>Hare</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Wosornu</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Lancashire</surname>
                      <given-names>RJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of left ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study</article-title>
                  <source>Lancet</source>
                  <year>2001</year>
                  <volume>358</volume>
                  <fpage>439</fpage>
                  <lpage>444</lpage>
                  <pub-id pub-id-type="pmid">11513906</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C23">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rutten</surname>
                      <given-names>FH</given-names>
                    </name>
                    <name>
                      <surname>Cramer</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Grobbe</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Rutten</surname>
                      <given-names>FH</given-names>
                    </name>
                    <name>
                      <surname>Cramer</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Grobbee1</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Sachs</surname>
                      <given-names>APE</given-names>
                    </name>
                    <name>
                      <surname>Kirkels</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Lammers</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Hoes</surname>
                      <given-names>AW</given-names>
                    </name>
                  </person-group>
                  <article-title>Unrecognised heart failure in elderly patients with stable chronic obstructive pulmonary disease</article-title>
                  <source>Eur Heart J</source>
                  <year>2005</year>
                  <volume>26</volume>
                  <fpage>1887</fpage>
                  <lpage>1894</lpage>
                  <pub-id pub-id-type="pmid">15860516</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C24">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Valle</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Chinellato</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gallo</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Milani</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Heart failure in nursing homes: prevalence, hospitalization, compliance to guidelines</article-title>
                  <source>Ital Heart J Suppl</source>
                  <year>2001</year>
                  <volume>2</volume>
                  <fpage>772</fpage>
                  <lpage>774</lpage>
                  <pub-id pub-id-type="pmid">11508295</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C25">
                <label>25</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dickstein</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Cohen-Solal</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Filippatos</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>McMurray</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Ponikowski</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Poole-Wilson</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>StrÃ¶mberg</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>van Veldhuisen</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Atar</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Hoes</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Keren</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mebazaa</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Nieminen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Priori</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Swedberg K;</surname>
                      <given-names>ESC</given-names>
                    </name>
                  </person-group>
                  <collab>Committee for Practice Guidelines (CPG)</collab>
                  <article-title>ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008<italic>. Eur J Heart Fail</italic></article-title>
                  <year>2008</year>
                  <volume>10</volume>
                  <fpage>933</fpage>
                  <lpage>989</lpage>
                </element-citation>
              </ref>
              <ref id="HFS165C26">
                <label>26</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rusinaru</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Leborgne</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Peltier</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Tribouilloy</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of atrial fibrillation on long-term survival in patients hospitalised for heart failure with preserved ejection fraction</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2008</year>
                  <volume>10</volume>
                  <fpage>566</fpage>
                  <lpage>572</lpage>
                  <pub-id pub-id-type="pmid">18456551</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C27">
                <label>27</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Owan</surname>
                      <given-names>TE</given-names>
                    </name>
                    <name>
                      <surname>Hodge</surname>
                      <given-names>DO</given-names>
                    </name>
                    <name>
                      <surname>Herges</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Jacobsen</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Roger</surname>
                      <given-names>VL</given-names>
                    </name>
                    <name>
                      <surname>Redfield</surname>
                      <given-names>MM</given-names>
                    </name>
                  </person-group>
                  <article-title>Trends in prevalence and outcome of heart failure with preserved ejection fraction</article-title>
                  <source>N Engl J Med</source>
                  <year>2006</year>
                  <volume>355</volume>
                  <fpage>251</fpage>
                  <lpage>259</lpage>
                  <pub-id pub-id-type="pmid">16855265</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C28">
                <label>28</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jong</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>McKelvie</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Yusuf</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?</article-title>
                  <source>BMJ</source>
                  <year>2010</year>
                  <volume>341</volume>
                  <fpage>c4202</fpage>
                  <pub-id pub-id-type="pmid">20739364</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C29">
                <label>29</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Folstein</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Folstein</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>McHugh</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Mini-Mental</surname>
                      <given-names>State</given-names>
                    </name>
                  </person-group>
                  <article-title>A practical method for grading the cognitive state of patients for the clinician</article-title>
                  <source>J Psychiatr Res</source>
                  <year>1975</year>
                  <volume>12</volume>
                  <fpage>189</fpage>
                  <lpage>198</lpage>
                  <pub-id pub-id-type="pmid">1202204</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C30">
                <label>30</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hodkinson</surname>
                      <given-names>HM</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of a mental test score for assessment of mental impairment in the elderly</article-title>
                  <source>Age Ageing</source>
                  <year>1972</year>
                  <volume>1</volume>
                  <fpage>233</fpage>
                  <lpage>238</lpage>
                  <pub-id pub-id-type="pmid">4669880</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C31">
                <label>31</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oppe</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Szende</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>de Charro</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Szende</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Oppe</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Devlin</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparative review of visual analogue scale value sets</article-title>
                  <source>EQ-5D Value Sets: Inventory, Comparative Review and User Guide</source>
                  <year>2007</year>
                  <volume>2</volume>
                  <publisher-loc>The Netherlands</publisher-loc>
                  <publisher-name>Springer</publisher-name>
                  <comment>EuroQoL Group Monographs</comment>
                </element-citation>
              </ref>
              <ref id="HFS165C32">
                <label>32</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Masani</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Wharton</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Allen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Chambers</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Graham</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rana</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Steeds</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <source>Echocardiography: Guidelines for Valve Quantification.</source>
                  <comment>British Society of Echocardiography Education Committee. <bold><uri xlink:type="simple" xlink:href="http://www.bsecho.org/media/40492/echo-pocket_a6_2011__3_.pdf">http://www.bsecho.org/media/40492/echo-pocket_a6_2011__3_.pdf</uri></bold> (April 2009)</comment>
                </element-citation>
              </ref>
              <ref id="HFS165C33">
                <label>33</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lang</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Bierig</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Devereux</surname>
                      <given-names>RB</given-names>
                    </name>
                    <name>
                      <surname>Flachskampf</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Foster</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pellikka</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Picard</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Roman</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Seward</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Shanewise</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Solomon</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Spencer</surname>
                      <given-names>KT</given-names>
                    </name>
                    <name>
                      <surname>St. John Sutton</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>Recommendations for chamber quantification</article-title>
                  <source>Eur J Echocardiogr</source>
                  <year>2006</year>
                  <volume>7</volume>
                  <fpage>79e108</fpage>
                  <pub-id pub-id-type="pmid">16458610</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C34">
                <label>34</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aronow</surname>
                      <given-names>WS</given-names>
                    </name>
                    <name>
                      <surname>Ahn</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Kronzon</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and Whites</article-title>
                  <source>Am J Cardiol</source>
                  <year>1999</year>
                  <volume>84</volume>
                  <fpage>611</fpage>
                  <lpage>612</lpage>
                  <pub-id pub-id-type="pmid">10482169</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C35">
                <label>35</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Valle</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Apsromonte</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Barro</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Canali</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Carbonieri</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Ceci</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Chinellato</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gallo</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Giovinazzo</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Ricci</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Milani</surname>
                    </name>
                  </person-group>
                  <article-title>The NT-proBNP assay identifies very elderly nursing home residents suffering from pre-clinical heart failure</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2005</year>
                  <volume>7</volume>
                  <fpage>542</fpage>
                  <lpage>551</lpage>
                  <pub-id pub-id-type="pmid">15921793</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C36">
                <label>36</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zhau</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zou</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Fu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ge</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction. A meta analysis of 7 prospective clinical studies</article-title>
                  <source>Int J Cardiol</source>
                  <year>2012</year>
                  <volume>155</volume>
                  <fpage>33</fpage>
                  <lpage>38</lpage>
                  <pub-id pub-id-type="pmid">21481482</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C37">
                <label>37</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Udelson</surname>
                      <given-names>JE</given-names>
                    </name>
                  </person-group>
                  <article-title>Heart failure with preserved ejection fraction</article-title>
                  <source>Circulation</source>
                  <year>2011</year>
                  <volume>124</volume>
                  <fpage>e540</fpage>
                  <lpage>e543</lpage>
                  <pub-id pub-id-type="pmid">22105201</pub-id>
                </element-citation>
              </ref>
              <ref id="HFS165C38">
                <label>38</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McMurray</surname>
                      <given-names>JJV</given-names>
                    </name>
                    <name>
                      <surname>Adamopoulos</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Anker</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Auricchio</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Boehm</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Dickstein</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Falk</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Filippatos</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Fonseca</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Sanchez</surname>
                      <given-names>MAG</given-names>
                    </name>
                    <name>
                      <surname>Jaarsma</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Kober</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lip</surname>
                      <given-names>GYH</given-names>
                    </name>
                    <name>
                      <surname>Maggioni</surname>
                      <given-names>AP</given-names>
                    </name>
                    <name>
                      <surname>Parkhomenko</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pieske</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Popescu</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Roennevik</surname>
                      <given-names>PK</given-names>
                    </name>
                    <name>
                      <surname>Rutten</surname>
                      <given-names>FH</given-names>
                    </name>
                    <name>
                      <surname>Schwitter</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Seferovic</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Stepinska</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Trindade</surname>
                      <given-names>PT</given-names>
                    </name>
                    <name>
                      <surname>Voors</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Zannad</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Zeiher</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2012</year>
                  <volume>14</volume>
                  <fpage>803</fpage>
                  <lpage>869</lpage>
                  <pub-id pub-id-type="pmid">22828712</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
